These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7532285)

  • 41. Transmission of Pseudomonas cepacia among cystic fibrosis patients.
    Millar-Jones L; Paull A; Saunders Z; Goodchild MC
    Lancet; 1992 Aug; 340(8817):491. PubMed ID: 1380626
    [No Abstract]   [Full Text] [Related]  

  • 42. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.
    Smith DL; Gumery LB; Smith EG; Stableforth DE; Kaufmann ME; Pitt TL
    J Clin Microbiol; 1993 Nov; 31(11):3017-22. PubMed ID: 7505294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudomonas cepacia in cystic fibrosis.
    Stableforth DE; Smith DL
    Thorax; 1994 Jul; 49(7):629-30. PubMed ID: 7520606
    [No Abstract]   [Full Text] [Related]  

  • 44. Practical management of cystic fibrosis.
    Elborn JS
    Chron Respir Dis; 2006; 3(3):161-5. PubMed ID: 16916010
    [No Abstract]   [Full Text] [Related]  

  • 45. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
    Taylor RF; Gaya H; Hodson ME
    J Antimicrob Chemother; 1992 Mar; 29(3):341-4. PubMed ID: 1375595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Burkholderia cepacia: another twist and a further threat.
    Webb AK; Govan JR
    Thorax; 1998 May; 53(5):333-4. PubMed ID: 9708220
    [No Abstract]   [Full Text] [Related]  

  • 47. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment.
    Fisher MC; LiPuma JJ; Dasen SE; Caputo GC; Mortensen JE; McGowan KL; Stull TL
    J Pediatr; 1993 Nov; 123(5):745-7. PubMed ID: 7693902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis.
    Lipuma JJ; Marks-Austin KA; Holsclaw DS; Winnie GB; Gilligan PH; Stull TL
    Pediatr Infect Dis J; 1994 Aug; 13(8):716-9. PubMed ID: 7526328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients.
    Hyde J; Humphreys H
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):253-4. PubMed ID: 9131333
    [No Abstract]   [Full Text] [Related]  

  • 50. Microbiology of cystic fibrosis lung infections: themes and issues.
    Govan JR; Nelson JW
    J R Soc Med; 1993; 86 Suppl 20(Suppl 20):11-8. PubMed ID: 7684788
    [No Abstract]   [Full Text] [Related]  

  • 51. Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis.
    Cimolai N; Trombley C; Davidson AG; Wong LT
    J Clin Pathol; 1995 May; 48(5):488-90. PubMed ID: 7543119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ventilator temperature sensors: an unusual source of Pseudomonas cepacia in nosocomial infection.
    Berthelot P; Grattard F; Mahul P; Jospe R; Pozzetto B; Ros A; Gaudin OG; Auboyer C
    J Hosp Infect; 1993 Sep; 25(1):33-43. PubMed ID: 7693802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis.
    Gessner AR; Mortensen JE
    J Med Microbiol; 1990 Oct; 33(2):115-20. PubMed ID: 2231677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pseudomonas cepacia in patients with cystic fibrosis attending the Royal Prince Alfred Hospital (RPAH).
    Teo C
    Pathology; 1993 Jan; 25(1):100. PubMed ID: 7686291
    [No Abstract]   [Full Text] [Related]  

  • 55. Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa.
    Pitt TL
    Thorax; 2002 Nov; 57(11):921. PubMed ID: 12403869
    [No Abstract]   [Full Text] [Related]  

  • 56. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.
    Tablan OC; Chorba TL; Schidlow DV; White JW; Hardy KA; Gilligan PH; Morgan WM; Carson LA; Martone WJ; Jason JM
    J Pediatr; 1985 Sep; 107(3):382-7. PubMed ID: 4032134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cystic fibrosis camps.
    Speert DP; LiPuma J; Ogle JW
    Pediatr Infect Dis J; 1993 Sep; 12(9):789. PubMed ID: 7692380
    [No Abstract]   [Full Text] [Related]  

  • 58. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment.
    Mortensen JE; Fisher MC; LiPuma JJ
    Infect Control Hosp Epidemiol; 1995 Jan; 16(1):30-2. PubMed ID: 7534780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.
    LiPuma JJ; Mortensen JE; Dasen SE; Edlind TD; Schidlow DV; Burns JL; Stull TL
    J Pediatr; 1988 Nov; 113(5):859-62. PubMed ID: 2903229
    [No Abstract]   [Full Text] [Related]  

  • 60. Identifying the killer in cystic fibrosis.
    Hearst JE; Elliott KE
    Nat Med; 1995 Jul; 1(7):626-7. PubMed ID: 7585137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.